{"id":"W4414947707","doi":"10.1177/17562848251383767","title":"Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Cilag; Samsung; Celgene; Biogen; Gilead Sciences; United European Gastroenterology; Celltrion; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Systematic review; Discontinuation; Infliximab; Inflammatory bowel disease; Ulcerative colitis; Ustekinumab; MEDLINE; Biosimilar","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000818117,0.0002856241,0.001048611,0.0001449922,0.00001625597,0.00000728344,0.0001260782,0.00004831656,0.000007550192],"category_scores_gemma":[0.00002226956,0.0001619845,0.0001499463,0.0002446534,0.0001388559,0.00002063564,0.00003465473,0.0000422524,3.128809e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006793316,"about_ca_system_score_gemma":0.00006173561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003005456,"about_ca_topic_score_gemma":0.0005760369,"domain_scores_codex":[0.9984276,0.000309927,0.0005289236,0.0003865742,0.0001100006,0.0002369791],"domain_scores_gemma":[0.9990363,0.00003789592,0.0002928728,0.0004673595,0.0001162522,0.00004931145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07054234,0.002451233,0.865526,0.01776078,0.03559576,0.0004262726,0.00104639,0.005845501,0.000104546,0.000277198,0.000003483933,0.0004204543],"study_design_scores_gemma":[0.02180535,0.01761453,0.8424087,0.005589332,0.1109419,0.00003426146,0.0002676638,0.0001307289,0.0003426564,0.00009852663,0.0001711747,0.0005950945],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9666025,0.03040443,0.0006585281,0.0001573789,0.00001173159,0.002039774,0.0001090001,0.000005155406,0.00001148844],"genre_scores_gemma":[0.9936703,0.005075711,0.0003448383,0.0002882328,0.000003709756,0.0004300903,0.00008325729,0.00001521737,0.00008862321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07534617,"threshold_uncertainty_score":0.6605536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01145679044322928,"score_gpt":0.2881641360656084,"score_spread":0.2767073456223791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}